Verizon Expands Field Presence as Starlink Remains in the Race
A Street View item says Verizon is strengthening its field presence while Starlink remains a competitor.
Related stories
Citi Cuts Suncorp Price Target After Premium Growth Forecast Trim
Citi lowered its price target on Suncorp after the insurer trimmed its annual premium growth forecast.
L impact | EQUITY | Oct 29, 2026, 11:01 PM UTC
Richards Group Reports Third-Quarter 2026 Results
Richards Group reported revenue growth of 2%, primarily from acquisitions, and gross margins up 7%.
M impact | EQUITY | Oct 29, 2026, 11:00 PM UTC
Global market picture: S&P 500 -1.08%, Nasdaq 100 -3.1%; EUR/USD +0.33%, WTI +0.05%
Global market picture. US index futures: S and P futures is down 1.08 percent, Nasdaq futures is down 3.1 percent, Dow futures is down 0.4 percent and Russell futures is up 0.92 pe
M impact | EQUITY | Oct 29, 2026, 11:00 PM UTC
Mapletree Pan Asia Commercial Trust Q2 Adjusted Revenue SGD 207.483 Million
M impact | EQUITY | Oct 29, 2026, 10:58 PM UTC
Twilio Raises Full-Year Revenue Growth Outlook to 20% After Higher 3Q Profit
Twilio said it now expects full-year revenue growth of 20%, up from its previous outlook of 18% to 18.5%, after reporting higher profit and revenue growth in the third quarter.
M impact | EQUITY | Oct 29, 2026, 10:57 PM UTC
Hanmi Pharmaceutical Licenses Fabry Disease Therapy to BioMarin for $237.5 Million
Hanmi Pharmaceutical licensed its Fabry disease therapy to BioMarin in a deal valued at USD 237.5 million.
M impact | EQUITY | Oct 29, 2026, 10:55 PM UTC